Medical therapy doses at hospital discharge in patients with existing and de novo heart failure

AIMS: Uptitrating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers (ACE‐I/ARBs), beta‐blockers, and mineralocorticoid receptor antagonists (MRAs) to optimal doses in heart failure with reduced ejection fraction (HFrEF) is associated with improved outcomes and recommended in...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamant, Michael J., Virani, Sean A., MacKenzie, Winston J., Ignaszewski, Andrew, Toma, Mustafa, Hawkins, Nathaniel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676447/
https://www.ncbi.nlm.nih.gov/pubmed/31218850
http://dx.doi.org/10.1002/ehf2.12454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676447/
https://www.ncbi.nlm.nih.gov/pubmed/31218850
http://dx.doi.org/10.1002/ehf2.12454

Ejemplares similares